A Structure-Guided Genetic Modification Strategy: Developing Seneca Valley Virus Therapy against Nonsensitive Nonsmall Cell Lung Carcinoma 🔗 Access full article via ASM Journal of VirologyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
